Cargando…

The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy

INTRODUCTION: In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five years. The aim of this study was to (1) assess the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Waaijer, M. E.C., Lemij, A. A., de Boer, A. Z., Bastiaannet, E., van den Bos, F., Derks, M. G.M., Kroep, J. R., Liefers, G. J., Portielje, J. E.A., de Glas, N. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460719/
https://www.ncbi.nlm.nih.gov/pubmed/37479944
http://dx.doi.org/10.1007/s10549-023-07029-4
_version_ 1785097693527277568
author Waaijer, M. E.C.
Lemij, A. A.
de Boer, A. Z.
Bastiaannet, E.
van den Bos, F.
Derks, M. G.M.
Kroep, J. R.
Liefers, G. J.
Portielje, J. E.A.
de Glas, N. A.
author_facet Waaijer, M. E.C.
Lemij, A. A.
de Boer, A. Z.
Bastiaannet, E.
van den Bos, F.
Derks, M. G.M.
Kroep, J. R.
Liefers, G. J.
Portielje, J. E.A.
de Glas, N. A.
author_sort Waaijer, M. E.C.
collection PubMed
description INTRODUCTION: In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five years. The aim of this study was to (1) assess the risk of distant metastases and other cause mortality over ten years in women aged 65 and older with stage I-III breast cancer treated with PET, (2) whether this was associated with geriatric characteristics and comorbidities and to (3) describe the reasons on which the choice for PET was made. METHODS: Women were included from the retrospective FOCUS cohort, which comprises all incident women diagnosed with breast cancer aged 65 or older between January 1997 and December 2004 in the Comprehensive Cancer Center Region West in the Netherlands. We selected women (N = 257) with stage I-III breast cancer and treated with PET from this cohort. Patient characteristics (including comorbidity, polypharmacy, walking, cognitive and sensory impairment), treatment and tumor characteristics were retrospectively extracted from charts. Outcomes were distant metastasis and other cause mortality. Cumulative incidences were calculated using the Cumulative Incidence for Competing Risks method (CICR); and subdistribution hazard ratios (SHR) were tested between groups based on age, geriatric characteristics and comorbidity with the Fine and Gray model. RESULTS: Women treated with PET were on average 84 years old and 41% had one or more geriatric characteristics. Other cause mortality exceeded the cumulative incidence of distant metastasis over ten years (83 versus 5.6%). The risk of dying from another cause further increased in women with geriatric characteristics (SHR 2.06, p < 0.001) or two or more comorbidities (SHR 1.72, p < 0.001). Often the reason for omitting surgery was not recorded (52.9%), but if recorded surgery was omitted mainly at the patient’s request (18.7%). DISCUSSION: This study shows that the cumulative incidence of distant metastasis is much lower than other cause mortality in older women with breast cancer treated with PET, especially in the presence of geriatric characteristics or comorbidities. This confirms the importance of assessment of geriatric characteristics to aid counseling of older women. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-023-07029-4.
format Online
Article
Text
id pubmed-10460719
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-104607192023-08-29 The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy Waaijer, M. E.C. Lemij, A. A. de Boer, A. Z. Bastiaannet, E. van den Bos, F. Derks, M. G.M. Kroep, J. R. Liefers, G. J. Portielje, J. E.A. de Glas, N. A. Breast Cancer Res Treat Epidemiology INTRODUCTION: In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five years. The aim of this study was to (1) assess the risk of distant metastases and other cause mortality over ten years in women aged 65 and older with stage I-III breast cancer treated with PET, (2) whether this was associated with geriatric characteristics and comorbidities and to (3) describe the reasons on which the choice for PET was made. METHODS: Women were included from the retrospective FOCUS cohort, which comprises all incident women diagnosed with breast cancer aged 65 or older between January 1997 and December 2004 in the Comprehensive Cancer Center Region West in the Netherlands. We selected women (N = 257) with stage I-III breast cancer and treated with PET from this cohort. Patient characteristics (including comorbidity, polypharmacy, walking, cognitive and sensory impairment), treatment and tumor characteristics were retrospectively extracted from charts. Outcomes were distant metastasis and other cause mortality. Cumulative incidences were calculated using the Cumulative Incidence for Competing Risks method (CICR); and subdistribution hazard ratios (SHR) were tested between groups based on age, geriatric characteristics and comorbidity with the Fine and Gray model. RESULTS: Women treated with PET were on average 84 years old and 41% had one or more geriatric characteristics. Other cause mortality exceeded the cumulative incidence of distant metastasis over ten years (83 versus 5.6%). The risk of dying from another cause further increased in women with geriatric characteristics (SHR 2.06, p < 0.001) or two or more comorbidities (SHR 1.72, p < 0.001). Often the reason for omitting surgery was not recorded (52.9%), but if recorded surgery was omitted mainly at the patient’s request (18.7%). DISCUSSION: This study shows that the cumulative incidence of distant metastasis is much lower than other cause mortality in older women with breast cancer treated with PET, especially in the presence of geriatric characteristics or comorbidities. This confirms the importance of assessment of geriatric characteristics to aid counseling of older women. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-023-07029-4. Springer US 2023-07-21 2023 /pmc/articles/PMC10460719/ /pubmed/37479944 http://dx.doi.org/10.1007/s10549-023-07029-4 Text en © The Author(s) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Epidemiology
Waaijer, M. E.C.
Lemij, A. A.
de Boer, A. Z.
Bastiaannet, E.
van den Bos, F.
Derks, M. G.M.
Kroep, J. R.
Liefers, G. J.
Portielje, J. E.A.
de Glas, N. A.
The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
title The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
title_full The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
title_fullStr The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
title_full_unstemmed The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
title_short The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
title_sort impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460719/
https://www.ncbi.nlm.nih.gov/pubmed/37479944
http://dx.doi.org/10.1007/s10549-023-07029-4
work_keys_str_mv AT waaijermec theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT lemijaa theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT deboeraz theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT bastiaannete theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT vandenbosf theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT derksmgm theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT kroepjr theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT liefersgj theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT portieljejea theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT deglasna theimpactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT waaijermec impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT lemijaa impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT deboeraz impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT bastiaannete impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT vandenbosf impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT derksmgm impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT kroepjr impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT liefersgj impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT portieljejea impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy
AT deglasna impactofgeriatriccharacteristicsandcomorbiditiesondistantmetastasesandothercausemortalityinolderwomenwithnonmetastaticbreastcancertreatedwithprimaryendocrinetherapy